The PROTECT Study: Everolimus Monotherapy vs. Calcineurin Inhibitor-Based Therapy over 35 Months Showed To Be a Safe Alternative with Superior Renal Function in Liver Transplant Recipients

Schlitt, H. J. and Kaiser, G. and Richter, N. and Heyne, N. and Rauchfuss, F. and Schemmee, P. and Fischer, L. and Paulus, E. -M. and Mertens, M. and Sterneck, M. (2013) The PROTECT Study: Everolimus Monotherapy vs. Calcineurin Inhibitor-Based Therapy over 35 Months Showed To Be a Safe Alternative with Superior Renal Function in Liver Transplant Recipients. LIVER TRANSPLANTATION, 19 (6Supp1). S88. ISSN 1527-6465, 1527-6473

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Chirurgie
Depositing User: Petra Gürster
Date Deposited: 16 Jun 2020 05:47
Last Modified: 16 Jun 2020 05:47
URI: https://pred.uni-regensburg.de/id/eprint/16607

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.